» Articles » PMID: 1734305

Myotonic Dystrophy: Clinical Assessment of Muscular Disability in an Isolated Population with Presumed Homogeneous Mutation

Overview
Journal Neurology
Specialty Neurology
Date 1992 Jan 1
PMID 1734305
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

We evaluated the muscular disability of 295 patients affected by the adult form of myotonic dystrophy (DM) and living in the Saguenay-Lac-Saint-Jean region (Quebec, Canada). The patients are known to have a common ancestral couple, and a homogeneous DM mutation is presumed. Using a five-point muscular disability rating scale (MDRS), we confirmed, in each age group, the wide expressivity of the muscular involvement usually observed in DM. Based on the duration of the disease and the MDRS, we also found a great variation in the rate of disease progression. There were no significant relationships between the rate of disease progression and the sex of the patient, the sex of the affected parent, or the age at onset of the disease. Furthermore, there was an absence of association between the age at onset and the sex of the patient or the sex of the affected parent. The variable severity of the muscular involvement, and the absence of relationship between age at onset and rate of disease progression, suggest a multiallelic influence at the DM locus or at other loci.

Citing Articles

Remimazolam for a patient with myotonic dystrophy type 1 who underwent endoscopic retrograde cholangiopancreatography under general anesthesia: a case report.

Fukuda M, Tachibana S, Nishihara N, Yamakage M JA Clin Rep. 2021; 7(1):17.

PMID: 33625620 PMC: 7905007. DOI: 10.1186/s40981-021-00422-2.


Stable Longitudinal Methylation Levels at the CpG Sites Flanking the CTG Repeat of in Patients with Myotonic Dystrophy Type 1.

Hildonen M, Knak K, Duno M, Vissing J, Tumer Z Genes (Basel). 2020; 11(8).

PMID: 32823742 PMC: 7465187. DOI: 10.3390/genes11080936.


Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes.

Overend G, Legare C, Mathieu J, Bouchard L, Gagnon C, Monckton D Hum Mol Genet. 2019; 28(13):2245-2254.

PMID: 31220271 PMC: 6586140. DOI: 10.1093/hmg/ddz055.


Design and conduct of the activated protein C and corticosteroids for human septic shock (APROCCHSS) trial.

Annane D, Buisson C, Cariou A, Martin C, Misset B, Renault A Ann Intensive Care. 2016; 6(1):43.

PMID: 27154719 PMC: 4859323. DOI: 10.1186/s13613-016-0147-3.


Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1).

Jean S, Richer L, Laberge L, Mathieu J Orphanet J Rare Dis. 2014; 9:186.

PMID: 25424323 PMC: 4247010. DOI: 10.1186/s13023-014-0186-5.